| |  Online-Ressource |
|---|
| Verfasst von: | El-Battrawy, Ibrahim [VerfasserIn]  |
|---|
| | Koepsel, Katharina [VerfasserIn] |
|---|
| | Tenbrink, David [VerfasserIn] |
|---|
| | Kovacs, Boldizsar [VerfasserIn] |
|---|
| | Dreher, Tobias C. [VerfasserIn] |
|---|
| | Blockhaus, Christian [VerfasserIn] |
|---|
| | Gotzmann, Michael [VerfasserIn] |
|---|
| | Klein, Norbert [VerfasserIn] |
|---|
| | Kuntz, Thomas [VerfasserIn] |
|---|
| | Shin, Dong‐In [VerfasserIn] |
|---|
| | Lapp, Hendrik [VerfasserIn] |
|---|
| | Rosenkaimer, Stephanie [VerfasserIn] |
|---|
| | Abumayyaleh, Mohammad S. A. [VerfasserIn] |
|---|
| | Hamdani, Nazha [VerfasserIn] |
|---|
| | Saguner, Ardan Muammer [VerfasserIn] |
|---|
| | Kowitz, Jacqueline [VerfasserIn] |
|---|
| | Erath, Julia W. [VerfasserIn] |
|---|
| | Duru, Firat [VerfasserIn] |
|---|
| | Mügge, Andreas [VerfasserIn] |
|---|
| | Akın, Ibrahim [VerfasserIn] |
|---|
| | Aweimer, Assem [VerfasserIn] |
|---|
| | Beiert, Thomas [VerfasserIn] |
|---|
| Titel: | Use of the wearable cardioverter‐defibrillator among patients with myocarditis and reduced ejection fraction or ventricular tachyarrhythmia |
|---|
| Titelzusatz: | data from a multicenter registry |
|---|
| Verf.angabe: | Ibrahim El‐Battrawy, MD; Katharina Koepsel; David Tenbrink; Boldizsar Kovacs, MD, MSc; Tobias C. Dreher; Christian Blockhaus, MD; Michael Gotzmann, MD; Norbert Klein, MD; Thomas Kuntz, MD; Dong‐In Shin, MD; Hendrik Lapp, MD; Stephanie Rosenkaimer, MD; Mohammad Abumayyaleh, MD; Nazha Hamdani, PhD; Ardan Muammer Saguner, MD; Jacqueline Kowitz; Julia W. Erath, MD; Firat Duru, MD; Andreas Mügge, MD, PhD; Ibrahim Akin, MD, PhD; Assem Aweimer, MD; Thomas Beiert, MD |
|---|
| E-Jahr: | 2023 |
|---|
| Jahr: | 19 September 2023 |
|---|
| Umfang: | 8 S. |
|---|
| Illustrationen: | Illustrationen |
|---|
| Fussnoten: | Online veröffentlicht: 8. September 2023 ; Gesehen am 08.08.2024 |
|---|
| Titel Quelle: | Enthalten in: American Heart AssociationJournal of the American Heart Association |
|---|
| Ort Quelle: | New York, NY : Association, 2012 |
|---|
| Jahr Quelle: | 2023 |
|---|
| Band/Heft Quelle: | 12(2023), 18, Artikel-ID e030615, Seite 1-8 |
|---|
| ISSN Quelle: | 2047-9980 |
|---|
| Abstract: | Background - Data on the use of the wearable cardioverter‐defibrillator (WCD) among patients with myocarditis remain sparse. Consequently, evidence for guideline recommendations in this patient population is lacking. - Methods and Results - In total, 1596 consecutive patients were included in a multicenter registry from 8 European centers, with 124 patients (8%) having received the WCD due to myocarditis and reduced left ventricular ejection fraction or prior ventricular tachyarrhythmia. The mean age was 51.6±16.3 years, with 74% being male. Patients were discharged after index hospitalization on heart failure medication: Angiotensin‐converting enzyme inhibitors (62.5%), angiotensin‐receptor‐neprilysin inhibitor (22.9%), aldosterone‐antagonists (51%), or beta blockers (91.4%). The initial median left ventricular ejection fraction was 30% (22%-45%) and increased to 48% (39%-55%) over long‐term follow‐up (P<0.001). The median BNP (brain natriuretic peptide) level at baseline was 1702 pg/mL (565-3748) and decreased to 188 pg/mL (26-348) over long‐term follow‐up (P=0.022). The mean wear time was 79.7±52.1 days and 21.0±4.9 hours per day. Arrhythmic event rates documented by the WCD were 9.7% for nonsustained ventricular tachycardia, 6.5% for sustained ventricular tachycardia, and 0% for ventricular fibrillation. Subsequently, 2.4% of patients experienced an appropriate WCD shock. The rate of inappropriate WCD shocks was 0.8%. All 3 patients with appropriate WCD shock had experienced ventricular tachycardia/ventricular fibrillation before WCD prescription, with only 1 patient showing a left ventricular ejection fraction <35%. - Conclusions - Patients with myocarditis and risk for occurrence of ventricular tachyarrhythmia may benefit from WCD use. Prior ventricular arrhythmia might appear as a better risk predictor than a reduced left ventricular ejection fraction <35% in this population. |
|---|
| DOI: | doi:10.1161/JAHA.123.030615 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
kostenfrei: Volltext: https://doi.org/10.1161/JAHA.123.030615 |
|---|
| | kostenfrei: Volltext: https://www.ahajournals.org/doi/10.1161/JAHA.123.030615 |
|---|
| | DOI: https://doi.org/10.1161/JAHA.123.030615 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| K10plus-PPN: | 1898169780 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Use of the wearable cardioverter‐defibrillator among patients with myocarditis and reduced ejection fraction or ventricular tachyarrhythmia / El-Battrawy, Ibrahim [VerfasserIn]; 19 September 2023 (Online-Ressource)
